Centogene Shares Outstanding 2019-2023 | CNTG

Centogene shares outstanding from 2019 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Centogene Annual Shares Outstanding
(Millions of Shares)
2022 27
2021 22
2020 21
2019 16
2018 287
Centogene Quarterly Shares Outstanding
(Millions of Shares)
2023-06-30
2022-06-30 27
2022-03-31 23
2021-12-31 22
2021-09-30 23
2021-06-30 22
2021-03-31 22
2020-12-31 21
2020-09-30 21
2020-06-30 20
2020-03-31 20
2019-09-30 327
2019-06-30
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.013B $0.050B
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.087B 0.00
IRhythm Technologies (IRTC) United States $3.621B 0.00
Axonics (AXNX) United States $3.390B 0.00
10x Genomics (TXG) United States $3.287B 0.00
Enovis (ENOV) United States $3.042B 23.11
Azenta (AZTA) United States $2.930B 238.82
Olink Holding AB (publ) (OLK) Sweden $2.760B 0.00
Hims & Hers Health (HIMS) United States $2.642B 0.00
Privia Health (PRVA) United States $2.231B 98.95
Schrodinger (SDGR) United States $1.794B 0.00
Omnicell (OMCL) United States $1.306B 31.94
Phreesia (PHR) United States $1.305B 0.00
Definitive Healthcare (DH) United States $0.856B 0.00
Standard BioTools (LAB) United States $0.743B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Talkspace (TALK) United States $0.530B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.162B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
American Well (AMWL) United States $0.157B 0.00
Butterfly Network (BFLY) United States $0.154B 0.00
Augmedix (AUGX) United States $0.138B 0.00
Outset Medical (OM) United States $0.127B 0.00
TruBridge (TBRG) United States $0.119B 5.06
111 (YI) China $0.091B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00